BNT329
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BNT329, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9 [Phase 1, Phase 2]